IL98849A0 - (2r)-2-(di-(2-propyl)phosphonylmethoxy)-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane,its preparation and use - Google Patents

(2r)-2-(di-(2-propyl)phosphonylmethoxy)-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane,its preparation and use

Info

Publication number
IL98849A0
IL98849A0 IL98849A IL9884991A IL98849A0 IL 98849 A0 IL98849 A0 IL 98849A0 IL 98849 A IL98849 A IL 98849A IL 9884991 A IL9884991 A IL 9884991A IL 98849 A0 IL98849 A0 IL 98849A0
Authority
IL
Israel
Prior art keywords
trimethylacetoxypropane
phosphonylmethoxy
toluenesulfonyloxy
propyl
preparation
Prior art date
Application number
IL98849A
Other languages
English (en)
Original Assignee
Ceskoslovenska Akademie Ved
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceskoslovenska Akademie Ved filed Critical Ceskoslovenska Akademie Ved
Publication of IL98849A0 publication Critical patent/IL98849A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL98849A 1990-08-06 1991-07-15 (2r)-2-(di-(2-propyl)phosphonylmethoxy)-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane,its preparation and use IL98849A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS903871A CS276072B6 (en) 1990-08-06 1990-08-06 (2R)-2-/DI(2-PROPYL)PHOSPHONYLMETHOXY/-3-p-TOLUENESULFONYLOXY -1- TRIMETHYLACETOXYPROPANE AND PROCESS FOR PREPARING THEREOF

Publications (1)

Publication Number Publication Date
IL98849A0 true IL98849A0 (en) 1992-07-15

Family

ID=5380072

Family Applications (1)

Application Number Title Priority Date Filing Date
IL98849A IL98849A0 (en) 1990-08-06 1991-07-15 (2r)-2-(di-(2-propyl)phosphonylmethoxy)-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane,its preparation and use

Country Status (13)

Country Link
US (2) US5130427A (cs)
EP (1) EP0470809A1 (cs)
JP (1) JP2955402B2 (cs)
AU (1) AU8149291A (cs)
CA (1) CA2046755C (cs)
CS (1) CS276072B6 (cs)
FI (1) FI913702A7 (cs)
IE (1) IE71217B1 (cs)
IL (1) IL98849A0 (cs)
NO (1) NO913035L (cs)
NZ (1) NZ239131A (cs)
PT (1) PT98590B (cs)
ZA (1) ZA915932B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ284678B6 (cs) * 1991-05-20 1999-01-13 Ústav Organické Chemie A Biochemie Avčr Di(2-propyl)estery 1-fluor-2-fosfonomethoxy-3-p -toluensulfonyloxypropanů, způsob jejich přípravy a použití
US6057305A (en) * 1992-08-05 2000-05-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Antiretroviral enantiomeric nucleotide analogs
JP2532818B2 (ja) 1993-02-01 1996-09-11 松下電器産業株式会社 対物レンズおよび光ヘッド装置
US5502177A (en) 1993-09-17 1996-03-26 Gilead Sciences, Inc. Pyrimidine derivatives for labeled binding partners
JP4555536B2 (ja) * 2000-02-18 2010-10-06 サザン・リサーチ・インスティテュート ２−クロロ−９−（２−デオキシ−２−フルオロ−β−Ｄ−アラビノフラノシル）−９Ｈ−プリン−６−アミンの合成方法
EA004926B1 (ru) 2000-07-21 2004-10-28 Джилид Сайэнс, Инк. Пролекарственные соединения фосфонатных аналогов нуклеотидов (варианты), способ их получения, способ скрининга для их идентификации и содержащая их композиция, способ антивирусной терапии или профилактики
CA2485597C (en) * 2002-05-13 2013-07-02 Metabasis Therapeutics, Inc. Process for preparation of cyclic prodrugs of pmea and pmpa
US7214668B2 (en) * 2002-05-13 2007-05-08 Metabasis Therapeutics, Inc. Phosphonic acid based prodrugs of PMEA and its analogues
US7582758B2 (en) * 2004-06-08 2009-09-01 Metabasis Therapeutics, Inc. Lewis acid mediated synthesis of cyclic esters
BR112013014485B1 (pt) 2010-12-10 2021-03-30 Sigmapharm Laboratories, Llc Composições farmacêuticas compreendendo pró-fármacos análogos de nucleotídeos de fosfonato ativos por via oral e sistema de embalagem de recipiente/fechamento contendo as ditas composições
EP2794624B1 (en) 2011-12-22 2019-05-15 Geron Corporation Guanine analogs as telomerase substrates and telomere length affectors
CA2937548C (en) 2014-02-13 2022-10-25 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
CN106687118A (zh) 2014-07-02 2017-05-17 配体药物公司 前药化合物及其用途
AU2019207625A1 (en) 2018-01-09 2020-07-30 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof
JP7151348B2 (ja) * 2018-10-03 2022-10-12 日本製鉄株式会社 金属板用塗料およびこれを用いた塗装金属板の製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868187A (en) * 1980-09-16 1989-09-19 Syntex (U.S.A.) Inc. Anti-viral N-substituted pyrimidines
US4816447A (en) * 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
CS233665B1 (en) * 1983-01-06 1985-03-14 Antonin Holy Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
AU8092587A (en) * 1986-11-18 1988-05-19 Bristol-Myers Squibb Company Synthesis of purin-9-ylalkylenoxymethyl phosphonic acids
US4927830A (en) * 1988-04-08 1990-05-22 The Regents Of The University Of Michigan Acyclic pyrrolo[2,3-D]pyrimidine analogs as antiviral agents
US4968686A (en) * 1988-04-08 1990-11-06 The Regents Of The University Of Michigan Acyclic pyrrolo [2,3-d]pyrimidine analogs as antiviral agents
WO1992002511A1 (en) * 1990-08-10 1992-02-20 Bristol-Myers Squibb Company Novel process for the preparation of nucleotides

Also Published As

Publication number Publication date
CA2046755A1 (en) 1992-02-07
NO913035D0 (no) 1991-08-05
USRE35558E (en) 1997-07-08
FI913702A0 (fi) 1991-08-02
NO913035L (no) 1992-02-07
IE71217B1 (en) 1997-02-12
NZ239131A (en) 1994-04-27
PT98590B (pt) 1999-04-30
JPH05230087A (ja) 1993-09-07
AU8149291A (en) 1992-02-13
PT98590A (pt) 1992-06-30
JP2955402B2 (ja) 1999-10-04
IE912758A1 (en) 1992-02-12
US5130427A (en) 1992-07-14
FI913702L (fi) 1992-02-07
ZA915932B (en) 1992-04-29
CA2046755C (en) 2002-02-12
EP0470809A1 (en) 1992-02-12
CS387190A3 (en) 1992-03-18
CS276072B6 (en) 1992-03-18
FI913702A7 (fi) 1992-02-07

Similar Documents

Publication Publication Date Title
IE900184L (en) Grisle wire for medical use.
PH30928A (en) Pharmaceutical agents.
EP0590208A3 (en) Dental articulator.
IL98849A0 (en) (2r)-2-(di-(2-propyl)phosphonylmethoxy)-3-p-toluenesulfonyloxy-1-trimethylacetoxypropane,its preparation and use
ZA951374B (en) Ranitidine solid dosage form
GB9017388D0 (en) Keratometer
ZA901879B (en) Medicament
GB8911259D0 (en) Inhalation medicament
PL286620A1 (en) Microbiocidal agent
EP0536311A4 (en) Compositions comprising vitamin d precursors, analogs thereof and their use
GB9000241D0 (en) Pharmaceutical use
IL109993A0 (en) Ipsapirone medicament formulation
CA63211S (en) Medicament applicator
GB8906442D0 (en) Inhalation formulation
GB9015923D0 (en) Further medical use
PL286247A1 (en) Microbiocidal agent
GB8916469D0 (en) Further medical use
GB9022669D0 (en) Medicament
ZA90840B (en) Medicament
GB2230444B (en) Therapeutic compositions.
AU102687S (en) Nomogram for medical use
GB8919545D0 (en) Anti-malignant therapeutic measures
GB9014231D0 (en) New pharmaceutical use
GB9004360D0 (en) New pharmaceutical use
GB9014229D0 (en) New pharmaceutical use